Related Experiment Video
Updated: Sep 21, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Transcriptional regulation of mitotic checkpoint gene MAD1 by p53
1Department of Biochemistry, the University of Hong Kong, Hong Kong, China.
Abstract:
p53 regulates a number of genes through transcriptional activation and repression. p53-dependent mitotic checkpoint has been described, but the underlying mechanism is still obscure. Here we examined the effect of p53 on the expression of a human mitotic checkpoint protein, Mitosis Arrest Deficiency 1 (MAD1), in cultured human cells. The expression of MAD1 was reduced when the cells were overexpressing exogenously introduced wild-type p53. The same reduction was also observed when the cells were treated with anticancer agents 5-fluorouracil and cisplatin or were irradiated with UV. Consistently, MAD1 promoter activity diminished in a dose-dependent manner when induced by p53, indicating that p53 repressed MAD1 at a transcriptional level. Intriguingly, several tumor hot spot mutations in p53 (V143A, R175H, R248W, and R273H) did not abolish the ability of p53 to repress MAD1 expression. By serial truncation of the MAD1 promoter, we confined the p53-responsive element to a 38-bp region that represents a novel sequence distinct from the known p53 consensus binding site. Trichostatin A, a histone deacetylase inhibitor, relieved the p53 transrepression activity on MAD1. Chromatin immunoprecipitation assay revealed that p53, histone deacetylase 1, and co-repressor mSin3a associated with the MAD1 promoter in vivo. Taken together, our findings suggest a regulatory mechanism for the mitotic checkpoint in which MAD1 is inhibited by p53.
Insights
The tumor suppressor p53 protein inhibits Mitosis Arrest Deficiency 1 (MAD1) expression transcriptionally. This finding reveals a novel mechanism regulating the mitotic checkpoint and cancer progression.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The tumor suppressor protein p53 is a key regulator of gene expression, involved in transcriptional activation and repression.
- While p53's role in the mitotic checkpoint is known, the precise molecular mechanisms remain unclear.
- Mitosis Arrest Deficiency 1 (MAD1) is a crucial human mitotic checkpoint protein.
Purpose of the Study:
- To investigate the effect of p53 on the expression of the human mitotic checkpoint protein MAD1.
- To elucidate the transcriptional regulation of MAD1 by p53.
Main Methods:
- Overexpression of wild-type p53 in cultured human cells.
- Treatment with anticancer agents (5-fluorouracil, cisplatin) and UV irradiation.
- Analysis of MAD1 promoter activity, p53-responsive elements, histone deacetylase inhibition, and chromatin immunoprecipitation assays.
Main Results:
- p53 overexpression and treatments inducing p53 activity reduced MAD1 expression.
- p53 repressed MAD1 transcription via a novel 38-bp element on the MAD1 promoter, independent of known p53 binding sites.
- Mutant p53 proteins retained the ability to repress MAD1; histone deacetylase inhibitors reversed this repression.
Conclusions:
- p53 directly represses MAD1 expression at the transcriptional level, involving histone deacetylase 1 and mSin3a.
- This provides a novel regulatory mechanism for the mitotic checkpoint.
- Understanding this p53-MAD1 interaction offers insights into cancer progression and potential therapeutic strategies.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
The Spindle Assembly Checkpoint
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
Inhibition of Cdk Activity

